Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
sortieren
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Atrial Fibrillation
97%
Recurrent Disease
92%
Diseases
57%
Congestive Heart Failure
53%
Heart Infarction
51%
Non ST Segment Elevation Myocardial Infarction
46%
ST Segment Elevation Myocardial Infarction
46%
Somatomedin Binding Protein 2
46%
Aortic Valve Stenosis
46%
Rivaroxaban
46%
Pulmonary Hypertension
46%
Persistent Atrial Fibrillation
46%
Hospital Mortality
46%
Beta Adrenergic Receptor Blocking Agent
46%
Coronavirinae
46%
Ischemic Cardiomyopathy
46%
microRNA
46%
Paroxysmal Atrial Fibrillation
46%
Sudden Cardiac Death
46%
Takotsubo Cardiomyopathy
46%
Cardiovascular Mortality
46%
Lipid
46%
Mitral Valve Regurgitation
46%
Low Density Lipoprotein Cholesterol
38%
Protein P53
23%
Infarction
23%
Cardiogenic Shock
23%
Ezetimibe
15%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Small Interfering RNA
15%
Urokinase Receptor
15%
Heart Ventricle Remodeling
12%
Enzyme-Linked Immunosorbent Assay
12%
Fatty Acid Binding Protein 3
10%
Vascular Cell Adhesion Molecule 1
10%
Growth Differentiation Factor 15
10%
Natriuretic Factor
10%
Heart Arrhythmia
9%
Cardiovascular Risk
9%
Comorbidity
9%
Cohort Study
7%
Heart Muscle Ischemia
7%
Statin (Protein)
7%
Retrospective Study
7%
Antiapoptotic
7%
Prevalence
7%
Monotherapy
7%
Diabetes Mellitus
7%
Random Effects Model
7%
Medicine and Dentistry
Atrial Fibrillation
46%
ST Segment Elevation Myocardial Infarction
46%
Aortic Valve Stenosis
46%
COVID-19
46%
Sudden Cardiac Death
46%
Rivaroxaban
46%
Heart-Type Fatty Acid Binding Protein
46%
Mitral Insufficiency
46%
Aortic Valve
46%
Myocardial Infarction
46%
Acute Coronary Syndrome
46%
Thorax Pain
46%
Computer Assisted Tomography
46%
Ischemic Cardiomyopathy
46%
Therapeutic Target
46%
microRNA
46%
Lipid
46%
Isotopes of Calcium
46%
Point-of-Care Testing
46%
Low Density Lipoprotein Cholesterol
38%
Statin
23%
Protein P53
23%
Infarction
23%
Emergency Department
19%
Thromboprophylaxis
17%
Secondary Prevention
15%
Ezetimibe
15%
Small Interfering RNA
15%
Cardiac Muscle Cell
15%
Cardiology
13%
Color Doppler Flowmetry
11%
Echocardiography
11%
Cardiovascular System
11%
Heart Valve
11%
Transthoracic Echocardiography
11%
Heart Left Ventricle Function
11%
Cohort Analysis
11%
Area under the Curve
9%
Biological Marker
7%
Retrospective Study
7%
Diabetes Mellitus
7%
Primary Prevention
7%
Monotherapy
7%
Next Generation Sequencing
7%
Treatment Group
7%
Programmed Cell Death
7%
Real-World Data
7%
Enzyme Linked Immunosorbent Assay
7%
Heart Ventricle Remodeling
7%
Hypertension
7%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
61%
Direct Current
46%
ST Elevation
46%
Heat Shock Protein
46%
Urokinase Receptor
46%
Heart-Type Fatty Acid Binding Protein
30%
Growth Differentiation Factor
30%
VCAM-1
30%
Natriuretic Peptide
20%
Lung Artery Pressure
19%
Troponin
15%
Kidney Function
15%
Enzyme
15%
Blood Level
6%
Cardiac Troponin
6%
Comorbidity
5%
Oxidative Stress
5%
Galectin-3
5%
Mitochondrial Disorder
5%
Fibroblast Growth Factor 23
5%
C-Reactive Protein
5%
Clinical Study
5%
